Five Oceans Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-531
Closed -$276K 186
2024
Q3
$276K Sell
531
-71
-12% -$37.9K 0.13% 132
2024
Q2
$326K Sell
602
-191
-24% -$101K 0.17% 99
2024
Q1
$411K Sell
793
-3
-0.4% -$1.49K 0.21% 78
2023
Q4
$375K Buy
796
+4
+0.5% +$1.85K 0.21% 86
2023
Q3
$345K Buy
792
+2
+0.3% +$907 0.22% 86
2023
Q2
$351K Buy
790
+96
+14% +$44.3K 0.23% 87
2023
Q1
$319K Sell
694
-64
-8% -$30.5K 0.21% 96
2022
Q4
$389K Sell
758
-32
-4% -$16.2K 0.27% 83
2022
Q3
$359K Buy
790
+295
+60% +$141K 0.28% 77
2022
Q2
$239K Buy
+495
New +$245K 0.18% 105

Other funds holding ELV

Five Oceans Advisors's ELV Position: Q4 2024 in Review

Five Oceans Advisors sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 531 shares — an estimated $276K sold.

Five Oceans Advisors first reported a position in ELV in Q2 2022 and held it in 10 quarters. The position peaked at $411K in Q1 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Five Oceans Advisors reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Five Oceans Advisors sold 531 Elevance Health shares in Q4 2024, an estimated $276K.
  • Five Oceans Advisors first reported a position in Elevance Health in Q2 2022 and held it in 10 quarters.
  • Five Oceans Advisors's Elevance Health position peaked at $411K in Q1 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Five Oceans Advisors's 13F filing for Q4 2024, filed 24 Jan 2025.